Drug Profile
Human papillomavirus vaccine - University of Southern California
Latest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator University of Southern California
- Class Cancer vaccines; Papillomavirus vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Human papillomavirus infections
Most Recent Events
- 24 Apr 2007 Discontinued - Phase-II for Human papillomavirus infections in USA (unspecified route)
- 11 Jan 2002 Phase-II clinical trials in Human papillomavirus infections in USA (unspecified route)
- 31 Mar 1999 Phase-I clinical trials in Human papillomavirus infections in USA (unspecified route)